1 – 10 of 59
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
In Situ Detection of Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Interactions as a Functional Predictor for Response to Immune Checkpoint Inhibition in NSCLC
2025) In Journal of Thoracic Oncology(
- Contribution to journal › Article
- 2024
-
Mark
Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
(
- Contribution to journal › Article
- 2023
-
Mark
Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Fibroblast subsets in non-small cell lung cancer : associations with survival, mutations, and immune features
(
- Contribution to journal › Article
-
Mark
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
(
- Contribution to journal › Article
- 2022
-
Mark
Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion
(
- Contribution to journal › Article
-
Mark
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
(
- Contribution to journal › Article